tradingkey.logo
tradingkey.logo

GSK Gets US FDA Approval For Arexvy In Adults Between 18-49 At Increased Risk

ReutersMar 13, 2026 10:47 AM

- GSK plc GSK.L:

  • GSK PLC - US FDA APPROVES AREXVY FOR ADULTS 18-49 AIR

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI